Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-08

Clinical Trial Update: Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD) [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and efficacy of intralesional HiLow hyaluronic acid for Peyronie's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HiLow Hyaluronic Acid (hyaluronic acid)

Snippet

Sponsor: IBSA Farmaceutici Italia Srl | Conditions: Peyronie Disease | NA | Status: COMPLETED